Przejdź do zawartości
Merck
Wszystkie zdjęcia(1)

Key Documents

GE17-5438-02

MabSelect SuRe

Cytiva 17-5438-02, pack of 200 mL

Synonim(y):

protein A affinity medium, affinity chromatography media

Zaloguj sięWyświetlanie cen organizacyjnych i kontraktowych


About This Item

Kod UNSPSC:
41106500
NACRES:
NA.56

ligand

alkali-stabilized protein A-derived (E. coli)

opakowanie

pack of 200 mL

producent / nazwa handlowa

Cytiva 17-5438-02

warunki przechowywania

(20% Ehtanol)

macierz

highly cross-linked agarose

śr. rozm. cząst.

85 μm (d₅₀v is the median particle size of the cumulative volume distribution)

cleaning in place

2-13.7

working range

3-12

pojemność

≥30 mg binding capacity (humanlgG/ml at 2.4 min residence time)

przydatność

suitable for bioprocess medium

temp. przechowywania

2-8°C

Powiązane kategorie

Opis ogólny

Determined at 10% breakthrough by frontal analysis at a mobile phase velocity of 500 cm/h in a column with a bed height of 20 cm.
MabSelect SuRe is a protein A affinity medium for capturing MAbs at process scale. MabSelect SuRe has an alkali-tolerant rProtein A ligand that allows the use of rigorous and cost-effective CIP and sanitization protocols based on 0.1 to 0.5 M NaOH. Further, the ligand is protease stable leading to lower ligand leakage.

MabSelect SuRe is a member of the MabSelect family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect SuRe shares features and benefits of MabSelect such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. In addition, MabSelect SuRe features an alkali-tolerant rProtein A ligand. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect SuRe improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl.

The novel ligand construct of MabSelect SuRe has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect SuRe ligand during elution is low. MabSelect SuRe has been demonstrated to give generic elution conditions for different monoclonal antibodies, which is an advantage when designing generic purification platform processes. This feature is also correlated to the construction of the MabSelect SuRe ligand.

MabSelect SuRe is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect SuRe meets industrial demands with security of supply and comprehensive technical and regulatory support.
pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.
pH below 3 is sometimes required to elute strongly bound IgG species. However, protein ligands may hydrolyze at very low pH.

Cechy i korzyści

  • Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH.
  • Reduces the risk of product contamination and carryover
  • Improves product quality and reduces overall costs
  • Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage
  • Generic elution profile for different monoclonal antibodies enables platform approach to purification
  • Used in the commercial manufacture of monoclonal antibodies
  • High-flow agarose matrix allows the processing of large feed volumes

Przechowywanie i stabilność

Please be aware this product may be shipped 90 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.

Komentarz do analizy

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Informacje prawne

Free MabSelect SuRe Ligand
"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
MabSelect is a trademark of Cytiva
SuRe is a trademark of Cytiva
This page may contain text that has been machine translated.

Piktogramy

Flame

Hasło ostrzegawcze

Warning

Zwroty wskazujące rodzaj zagrożenia

Zwroty wskazujące środki ostrożności

Kod klasy składowania

3 - Flammable liquids


Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

Klienci oglądali również te produkty

Produkty

Capto adhere from GE Healthcare is a multimodal strong anion exchanger for BioProcess applications.

Description of viral clearance using Capto adhere from GE Healthcare.

This page describes the difference between bind/elute and flowthrough modes in multimodal chromatography using GE Healthcare products.

This page describes the optimization of loading conditions on Capto adhere from GE Healthcare using full factorial design of experiments (DoE).

Zobacz wszystko

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej